Melittin-Based Nano-Delivery Systems for Cancer Therapy
Melittin (MEL) is a 26-amino acid polypeptide with a variety of pharmacological and toxicological effects, which include strong surface activity on cell lipid membranes, hemolytic activity, and potential anti-tumor properties. However, the clinical application of melittin is restricted due to its se...
Main Authors: | Anqi Wang, Yuan Zheng, Wanxin Zhu, Liuxin Yang, Yang Yang, Jinliang Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/1/118 |
Similar Items
-
Genetically engineered nano‐melittin vesicles for multimodal synergetic cancer therapy
by: Jianzhong Zhang, et al.
Published: (2023-11-01) -
Redox-Sensitive Nanocomplex for Targeted Delivery of Melittin
by: Bei Cheng, et al.
Published: (2020-09-01) -
A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety
by: Jie Mao, et al.
Published: (2017-03-01) -
New N-Terminal Fatty-Acid-Modified Melittin Analogs with Potent Biological Activity
by: Sheng Huang, et al.
Published: (2024-01-01) -
Delivery of Melittin as a Lytic Agent via Graphene Nanoparticles as Carriers to Breast Cancer Cells
by: Karolina Daniluk, et al.
Published: (2022-12-01)